Can Bullous Pemphigoid Be Cured? What Remission Means

Because bullous pemphigoid (BP) is a chronic autoimmune disease, it is not usually “cured” in the traditional sense of permanent eradication. However, it is highly treatable, and many patients achieve clinical remission—a state where the disease becomes inactive and symptoms resolve. With careful management over time, some people can safely stop taking medications, though long-term monitoring remains necessary.

Important Safety Warning: Never reduce or stop your medications on your own. Abruptly stopping oral steroids or other immunosuppressants can cause severe withdrawal symptoms, adrenal problems, and trigger a rapid return of blistering. Always follow your prescriber’s tapering plan.

Understanding Remission

Instead of aiming for a permanent cure, dermatologists aim for clinical remission. This means your symptoms (blisters, hives, and severe itching) are controlled, even though the underlying autoimmune tendency may persist. Remission can take different forms:

• Remission on therapy: You have no active blisters or severe itching, but you still require regular medication to keep the disease inactive.
• Remission off therapy: You have no active symptoms and have been successfully tapered off all BP medications.

Achieving complete remission off all treatment is possible, but timelines vary based on age, overall health, and disease severity. In one large study of patients with BP, about 10.9% achieved complete remission off all therapies after one year. This cumulative rate increased to 32.9% by three years, and 47.5% by five years ^[1]. While stopping all medication is a realistic goal for some, others may need to remain on low-dose treatments long-term to keep the disease inactive.

Tapering Medications and Relapse Risks

Treatment for BP often involves potent topical steroids (creams), systemic oral steroids (like prednisone), or steroid-sparing immunosuppressants. Once the disease is well-controlled, your doctor will likely initiate a slow, supervised tapering process to find the lowest effective dose ^[2][3].

Because BP is an autoimmune condition, there is a risk that symptoms will flare up again (relapse). Group studies estimate that between 28% and 53% of patients experience a relapse after reaching remission ^[4]. Many of these relapses occur within the first six months after stopping treatment entirely, though they can also happen months or years later ^[5][6].

How Doctors Monitor the Risk

Your doctor will primarily rely on your clinical symptoms to guide your treatment. In some cases, specialists might also use tests as optional tools to help assess the risk of relapse:

• Anti-BP180 antibodies: These are the specific immune proteins that attack the skin in BP. A significant drop in these antibody levels is often linked to a more successful taper and a lower risk of relapse ^[7]. However, antibody levels do not perfectly match symptoms for everyone, and this blood test is just one piece of the puzzle.
• Direct immunofluorescence: This specialized skin biopsy checks for immune proteins in the tissue. While a persistently positive test at the end of treatment might indicate a higher relapse risk ^[6], repeat biopsies are not routine. The decision to stop treatment is based mainly on your clinical stability, not just test results.

Managing the Long-Term Outlook

Because bullous pemphigoid predominantly affects older adults, managing it requires balancing the need to control the blisters with the side effects of medications ^[8]. High doses of systemic steroids and immunosuppressants carry risks such as serious infections, elevated blood sugar, high blood pressure, and bone loss (osteoporosis) ^[9].

Your care team’s goal is to minimize your exposure to these medication risks while keeping your skin clear. They will monitor your overall health, manage side effects, and work with you to keep the disease as quiet as possible for the long term.